Literature DB >> 15772466

Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000.

Hermann L Müller1, Ursel Gebhardt, Nicole Etavard-Gorris, Reinhard Kolb, Monika Warmuth-Metz, Niels Sörensen.   

Abstract

Craniopharyngiomas are rare dysontogenetic malformations. As the survival rate after craniopharyngioma diagnosed during childhood and adolescence is high, prognosis and quality of life (QoL) in survivors mainly depend on adverse late effects such as hypopituitarism and obesity. Appropriate laboratory diagnostics of endocrine deficiencies and sufficient hormonal substitution have significant impact on prognosis and QoL. In order to evaluate and standardize diagnostic and therapeutical strategies in childhood craniopharyngioma the prospective multicenter surveillance study KRANIOPHARYNGEOM 2000 was initiated for patients diagnosed with craniopharyngioma during childhood and adolescence. We are reporting on current strategies for laboratory diagnostics and endocrine substitution in patients with childhood craniopharyngioma recruited in KRANIOPHARYNGEOM 2000.

Entities:  

Mesh:

Year:  2005        PMID: 15772466     DOI: 10.1159/000083671

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  4 in total

Review 1.  Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2010-09-28       Impact factor: 43.330

2.  Craniopharyngioma: The Benefits of a Conservative Approach.

Authors:  Hans Clusmann; Anke Höllig
Journal:  Dtsch Arztebl Int       Date:  2019-05-03       Impact factor: 5.594

3.  Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives.

Authors:  Hermann L Müller
Journal:  Int J Endocrinol       Date:  2010-12-16       Impact factor: 3.257

4.  Treatment strategies in childhood craniopharyngioma.

Authors:  Stéphanie Puget
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-05       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.